Basic information Safety Supplier Related

5-(4-BROMOPHENYL)-5-OXOVALERIC ACID

Basic information Safety Supplier Related

5-(4-BROMOPHENYL)-5-OXOVALERIC ACID Basic information

Product Name:
5-(4-BROMOPHENYL)-5-OXOVALERIC ACID
Synonyms:
  • 5-(4-BROMOPHENYL)-5-OXOVALERIC ACID
  • OTAVA-BB 1043539
  • UKRORGSYN-BB BBV-213517
  • Benzenepentanoic acid, 4-bromo-δ-oxo-
  • 4-Bromo-δ-oxobenzenepentanoic acid
CAS:
35333-26-7
MF:
C11H11BrO3
MW:
271.11
EINECS:
233-305-4
Mol File:
35333-26-7.mol
More
Less

5-(4-BROMOPHENYL)-5-OXOVALERIC ACID Chemical Properties

Melting point:
116-118 °C(Solv: ethyl acetate (141-78-6); hexane (110-54-3))
Boiling point:
442.3±30.0 °C(Predicted)
Density 
1.495±0.06 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
pka
4.58±0.10(Predicted)
More
Less

5-(4-BROMOPHENYL)-5-OXOVALERIC ACID Usage And Synthesis

Synthesis

108-55-4

108-86-1

35333-26-7

Anhydrous aluminum trichloride (78.8 mmol, 10.5 g, 2.3 eq.) and anhydrous dichloromethane (25 mL) were added to the flask under a protective tube of calcium chloride and the resulting suspension was stirred in an ice bath. Subsequently, a solution of anhydrous dichloromethane (15 mL) with glutaric anhydride (34.3 mmol, 3.91 g) was added slowly dropwise, keeping the reaction temperature below 7 °C. The reaction was carried out in an ice bath. After the dropwise addition was completed, stirring was continued in an ice bath for 30 min, and then bromobenzene (34.3 mmol, 5.39 g, 1.0 eq.) was carefully added. The ice bath was removed and the reaction mixture was stirred at room temperature for 19 hours. Upon completion of the reaction, the mixture was poured into ice water (15 mL) and acidified with concentrated hydrochloric acid. The aqueous layer was washed with sodium sulfate (10 mL) and the organic phase was extracted with ethyl acetate (1 × 100 mL, 2 × 50 mL). The organic phases were combined, dried with anhydrous sodium sulfate, filtered and concentrated. The crude product was dissolved in ethyl acetate and this solution was added slowly dropwise to cold hexane (1 L) with vigorous stirring. The precipitate was collected by filtration and dried to give 5-(4-bromophenyl)-5-oxovaleric acid (7.93 g, 85%) as a yellow powder with a melting point of 125-127 °C.1H NMR (300 MHz, CDCl3): δ= 2.07 (m, 2H), 2.50 (t, J = 7.2 Hz, 2H), 3.04 (t, J = 7.2 Hz, 2H), 7.60 (m, 2H). 7.60 (m, 2H), 7.82 (m, 2H). 5-(4-Bromophenyl)-5-oxovaleric acid (25.0 mmol, 6.78 g), paraformaldehyde (86.3 mmol, 2.59 g, 3.4 eq.), and piperidine (0.57 mL, 0.24 eq.) were dissolved/suspended in pyridine (42 mL) and stirred for 21 hr. at 70 °C. Upon completion of the reaction, the mixture was poured into a mixture of 1 M sulfuric acid (200 mL) and concentrated hydrochloric acid. The aqueous layer was washed with sodium sulfate (15 mL) and the organic phase was extracted with ethyl acetate (1 × 150 mL, 2 × 100 mL). The organic phases were combined, washed with half-saturated brine (300 mL), dried over anhydrous sodium sulfate, filtered and concentrated. The crude product was crystallized with ethyl acetate to give 4-(4-bromobenzoyl)pent-4-enoic acid (3.93 g, 56%) as an orange-yellow solid with a melting point of 127-128 °C. 1H NMR (300 MHz, CDCl3): δ= 2.63 (t, J = 6.9 Hz, 2H), 2.80 (t, J = 6.9 Hz, 2H), 5.67 (s, 1H) , 5.95 (s, 1H), 7.60 (m, 4H); 13C NMR (75 MHz, CDCl3): δ= 27.2, 32.6, 127.3, 127.4, 131.0, 131.6, 136.3, 145.8, 178.9, 196.6.

References

[1] Russian Journal of General Chemistry, 2014, vol. 84, # 9, p. 1825 - 1829
[2] Zhurnal Obshchei Khimii, 2014, vol. 84, # 9, p. 1825 - 1829,5
[3] Tetrahedron Letters, 2016, vol. 57, # 10, p. 1079 - 1082
[4] Heterocycles, 2005, vol. 65, # 3, p. 649 - 656

5-(4-BROMOPHENYL)-5-OXOVALERIC ACIDSupplier

Shanghai Jian Chao Chemical Technology Co., Ltd.
Tel
150-2103-5486 18017383231
Email
983544897@qq.com
Suzhou Ryan Pharmachem Technology Co.,Ltd
Tel
0512-66585217 13962137180
Email
sales@ryanchem.com
Shanghai KaiYuLin pharmaceutical technology co., LTD
Tel
021-18721936-595 18721936595
Email
shkylpharma@126.com
Zhengzhou Guancheng Laboratory equipment Sales
Tel
0371-88888888 272369594
Email
2723695949@qq.com
Nanjing Huang Tai Pharmaceutical Technology Co. Ltd.
Tel
025-58803135 18551845925
Email
3569572487@qq.com